Yes, but it would be an off-label use since Mounjaro is FDA-approved for type 2 diabetes, not obesity
Following synthesis, purification is performed using high-performance liquid chromatography (HPLC) to achieve high purity
Zhang L, Zhang L, Li Y, Li L, Melchiorsen JU, Rosenkilde M, et al
65 In a meta-analysis by He et al, which included 76 RCTs covering more than 100,000 overweight or obese individuals, GLP-1 RA use was reported to increase the risk of gallbladder stones or biliary tract disease by 37% (RR 1.37 [95% CI 1.231.52])
When your target dose is small, a sloppy draw can swing your real intake by a large percentage, which makes tracking your response meaningless
The side effect onset timeline varies, but most people who will experience GI symptoms feel them within the first 48 hours post-injection